Similarly, it has been reported that TZD inhibits the proliferation of human NSCLC NCI-H23 cells and that these effects are associated with ERK1/2 activation and SAPK/JNK deactivation [27]. The gene discussed is MAPK8; the disease is non-small cell lung carcinoma.